AIC
VYNT

Ameritas Investment Company’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Ameritas Investment Company’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-20
Closed – – 1706
2020
Q1 		$0 Buy
+20
New +$406 ﹤0.01% 1855
2019
Q2 		– Sell
-20
Closed -$1K – 931
2019
Q1 		$1K Buy
+20
New +$822 ﹤0.01% 917

Other funds holding VYNT

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fifth Third Bancorp
Fifth Third Bancorp Cincinnati, Ohio $61.7B AUM 33.76% 1-Year Est. Return
MC
Mayo Clinic Rochester, Minnesota $2.9M AUM 14.49% 1-Year Est. Return

Ameritas Investment Company's VYNT Position: Q2 2020 in Review

Ameritas Investment Company sold out of Vyant Bio, Inc. Common Stock (VYNT) in Q2 2020, closing a stake of 20 shares.

Ameritas Investment Company first reported a position in VYNT in Q1 2019 and held it in 2 quarters. The position peaked at $1K in Q1 2019. 12 funds tracked by Wall St. Rank hold VYNT as of Q2 2020.

  • Ameritas Investment Company reported no remaining Vyant Bio, Inc. Common Stock position as of Q2 2020 after selling out during the quarter.
  • Ameritas Investment Company sold 20 Vyant Bio, Inc. Common Stock shares in Q2 2020.
  • Ameritas Investment Company first reported a position in Vyant Bio, Inc. Common Stock in Q1 2019 and held it in 2 quarters.
  • Ameritas Investment Company's Vyant Bio, Inc. Common Stock position peaked at $1K in Q1 2019.
  • 12 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q2 2020.

Based on Ameritas Investment Company's 13F filing for Q2 2020, filed 14 Aug 2020.